Authors:
YAZAWA N
FUJIMOTO M
KIKUCHI K
KUBO M
IHN H
SATO S
TAMAKI T
TAMAKI K
Citation: N. Yazawa et al., HIGH SEROPREVALENCE OF HELICOBACTER-PYLORI INFECTION IN PATIENTS WITHSYSTEMIC-SCLEROSIS - ASSOCIATION WITH ESOPHAGEAL INVOLVEMENT, Journal of rheumatology, 25(4), 1998, pp. 650-653
Authors:
KADONO T
KIKUCHI K
IHN H
TAKEHARA K
TAMAKI K
Citation: T. Kadono et al., INCREASED PRODUCTION OF INTERLEUKIN-6 AND INTERLEUKIN-8 IN SCLERODERMA FIBROBLASTS, Journal of rheumatology, 25(2), 1998, pp. 296-301
Authors:
HASEGAWA M
SATO S
FUJIMOTO M
IHN H
KIKUCHI K
TAKEHARA K
Citation: M. Hasegawa et al., SERUM LEVELS OF INTERLEUKIN-6 (IL-6), ONCOSTATIN-M, SOLUBLE IL-6 RECEPTOR, AND SOLUBLE GP130 IN PATIENTS WITH SYSTEMIC-SCLEROSIS, Journal of rheumatology, 25(2), 1998, pp. 308-313
Authors:
SATO S
HASEGAWA M
NAGAOKA T
TAKAMATSU Y
YAZAWA N
IHN H
KIKUCHI K
TAKEHARA K
Citation: S. Sato et al., AUTOANTIBODIES AGAINST CALPASTATIN IN SERA FROM PATIENTS WITH SYSTEMIC-SCLEROSIS, Journal of rheumatology, 25(11), 1998, pp. 2135-2139
Citation: T. Kadono et al., INCREASED PRODUCTION OF INTERLEUKIN-6 AND INTERLEUKIN-8 IN SCLERODERMA FIBROBLASTS, Journal of investigative dermatology, 110(4), 1998, pp. 663-663
Authors:
KAWAKAMI T
IHN H
XU WD
SMITH E
LEROY C
TROJANOWSKA M
Citation: T. Kawakami et al., INCREASED EXPRESSION OF TGF-BETA RECEPTORS BY SCLERODERMA FIBROBLASTS- EVIDENCE FOR CONTRIBUTION OF AUTOCRINE TGF-BETA SIGNALING TO SCLERODERMA PHENOTYPE, Journal of investigative dermatology, 110(1), 1998, pp. 47-51
Citation: H. Ihn et M. Trojanowska, SP3 IS A TRANSCRIPTIONAL ACTIVATOR OF THE HUMAN ALPHA-2(I) COLLAGEN GENE, Nucleic acids research, 25(18), 1997, pp. 3712-3717
Authors:
IHN H
SATO S
FUJIMOTO M
KIKUCHI K
KADONO T
TAMAKI K
TAKEHARA K
Citation: H. Ihn et al., CIRCULATING INTERCELLULAR-ADHESION MOLECULE-1 IN THE SERA OF PATIENTSWITH SYSTEMIC-SCLEROSIS - ENHANCEMENT BY INFLAMMATORY CYTOKINES, British journal of rheumatology, 36(12), 1997, pp. 1270-1275
Citation: H. Ihn et al., ONCOSTATIN-M STIMULATES TRANSCRIPTION OF THE HUMAN ALPHA-2(I) COLLAGEN GENE VIA THE SP1 SP3-BINDING SITE/, The Journal of biological chemistry, 272(39), 1997, pp. 24666-24672
Authors:
FUJIMOTO M
KIKUCHI K
TAMAKI T
YAZAWA N
KUBO M
IHN H
SATO S
SOMA Y
TAMAKI K
Citation: M. Fujimoto et al., DISTRIBUTION OF ANTI-P80-COILIN AUTOANTIBODY IN COLLAGEN DISEASES ANDVARIOUS SKIN DISEASES, British journal of dermatology, 137(6), 1997, pp. 916-920
Citation: M. Trojanowska et al., CHARACTERIZATION OF A NOVEL CIS-ACTING ELEMENT REQUIRED FOR BASAL ACTIVITY AND ONCOSTATIN-M STIMULATION OF THE HUMAN ALPHA-2(I) COLLAGEN GENE, Arthritis and rheumatism, 40(9), 1997, pp. 1020-1020
Citation: M. Trojanowska et H. Ihn, SP3 IS A TRANSCRIPTIONAL ACTIVATOR OF THE HUMAN ALPHA-2(I) COLLAGEN GENE, Arthritis and rheumatism, 40(9), 1997, pp. 1023-1023
Authors:
TROJANOWSKA M
KAWAKAMI T
IHN H
XU WD
SMITH E
LEROY EC
Citation: M. Trojanowska et al., INCREASED EXPRESSION OF TGF-BETA RECEPTORS BY SCLERODERMA FIBROBLASTS- EVIDENCE FOR CONTRIBUTION OF AUTOCRINE TGF-BETA SIGNALING TO SCLERODERMA PHENOTYPE, Arthritis and rheumatism, 40(9), 1997, pp. 1589-1589
Authors:
FUJIMOTO M
SHIMOZUMA M
YAZAWA N
KUBO M
IHN H
SATO S
TAMAKI T
KIKUCHI K
TAMAKI K
Citation: M. Fujimoto et al., PREVALENCE AND CLINICAL RELEVANCE OF 52-KDA AND 60-KDA RO SS-A AUTOANTIBODIES IN JAPANESE PATIENTS WITH SYSTEMIC-SCLEROSIS/, Annals of the Rheumatic Diseases, 56(11), 1997, pp. 667-670
Authors:
SATO S
FUJIMOTO M
KIKUCHI K
IHN H
TAMAKI K
TAKEHARA K
Citation: S. Sato et al., SOLUBLE CD4 AND CD8 IN SERUM FROM PATIENTS WITH LOCALIZED SCLERODERMA, Archives of dermatological research, 288(7), 1996, pp. 358-362
Authors:
SATO S
FUJIMOTO M
KIKUCHI K
IHN H
TAMAKI K
TAKEHARA K
Citation: S. Sato et al., ELEVATED SOLUBLE CD23 LEVELS IN THE SERA FROM PATIENTS WITH LOCALIZEDSCLERODERMA, Archives of dermatological research, 288(2), 1996, pp. 74-78
Authors:
IGARASHI A
NASHIRO K
KIKUCHI K
SATO S
IHN H
FUJIMOTO M
GROTENDORST GR
TAKEHARA K
Citation: A. Igarashi et al., CONNECTIVE-TISSUE GROWTH-FACTOR GENE-EXPRESSION IN TISSUE-SECTIONS FROM LOCALIZED SCLERODERMA, KELOID, AND OTHER FIBROTIC SKIN DISORDERS, Journal of investigative dermatology, 106(4), 1996, pp. 729-733
Authors:
IHN H
OHNISHI K
TAMAKI T
LEROY EC
TROJANOWSKA M
Citation: H. Ihn et al., TRANSCRIPTIONAL REGULATION OF THE HUMAN ALPHA-2(I) COLLAGEN GENE - COMBINED ACTION OF UPSTREAM STIMULATORY AND INHIBITORY CIS-ACTING ELEMENTS, The Journal of biological chemistry, 271(43), 1996, pp. 26717-26723
Authors:
IHN H
SATO S
FUJIMOTO M
KIKUCHI K
IGARASHI A
SOMA Y
TAMAKI K
TAKEHARA K
Citation: H. Ihn et al., MEASUREMENT OF ANTICARDIOLIPIN ANTIBODIES BY ELISA USING BETA(2)-GLYCOPROTEIN-I (BETA(2)-GPI) IN SYSTEMIC-SCLEROSIS, Clinical and experimental immunology, 105(3), 1996, pp. 475-479
Authors:
FUJIMOTO M
SATO S
IHN H
TAMAKI T
KIKUCHI K
SOMA Y
TAMAKI K
Citation: M. Fujimoto et al., AUTOANTIBODIES TO MITOCHONDRIAL 2-OXO-ACID DEHYDROGENASE COMPLEXES INLOCALIZED SCLERODERMA, Clinical and experimental immunology, 105(2), 1996, pp. 297-301
Authors:
IHN H
SATO S
FUJIMOTO M
KIKUCHI K
TAKEHARA K
Citation: H. Ihn et al., CLINICAL-SIGNIFICANCE OF SERUM LEVELS OF SOLUBLE INTERLEUKIN-2 RECEPTOR IN PATIENTS WITH LOCALIZED SCLERODERMA, British journal of dermatology, 134(5), 1996, pp. 843-847
Authors:
TROJANOWSKA M
LUBINUS M
OHNISHI K
IHN H
LEROY EC
Citation: M. Trojanowska et al., TGF-BETA INDUCES PHOSPHORYLATION OF TRANSCRIPTION FACTOR SP1 AND MODULATES BINDING TO THE SP1 RESPONSIVE ELEMENT IN HUMAN COLLAGEN ALPHA-2(I) PROMOTER IN-VIVO, Molecular biology of the cell, 6, 1995, pp. 254-254
Authors:
KIKUCHI K
KADONO T
FUJIMOTO M
IHN H
SATO S
TAKEHARA K
Citation: K. Kikuchi et al., ELEVATED PROCOLLAGEN TYPE-I CARBOXYTERMINAL PROPEPTIDE PRODUCTION IN CULTURED SCLERODERMA FIBROBLASTS, Dermatology, 190(2), 1995, pp. 104-108
Citation: M. Fujimoto et al., AUTOANTIBODIES TO THE HEAT-SHOCK PROTEIN HSP73 IN LOCALIZED SCLERODERMA, Archives of dermatological research, 287(6), 1995, pp. 581-585
Authors:
IHN H
SATO S
FUJIMOTO M
KIKUCHI K
TAKEHARA K
Citation: H. Ihn et al., DEMONSTRATION OF INTERLEUKIN-2, INTERLEUKIN-4 AND INTERLEUKIN-6 IN SERA FROM PATIENTS WITH LOCALIZED SCLERODERMA, Archives of dermatological research, 287(2), 1995, pp. 193-197